Summary
Using growth factors-defined and serum—free culture media, we have shown that phenotypic transformation of normal rat kidney cells does not require specific polypeptide growth factors but more generally reflects the ability of these cells to respond to multiple growth factors. Epidermal growth factor and platelet-derived growth factor contribute to this process by a direct mitogenic action on these cells, modulating agents like transforming growth factor—β and retinoic acid have an indirect growth stimulating effect. Some aspects of the mechanism whereby these modulating agents can exert their action will be discussed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Anzano MA, Roberts AB, Meyers CA, Komoriya A, Lamb LC, Smith JM, Sporn MB (1982) Synergistic interaction of two classes of transforming growth factors from murine sarcoma cells. Cancer Res. 42:4776–4778
Assoian RK, Komoriya A, Meyers CA, Miller DM, Sporn MB (1983) Transforming growth factor-β in human platelets. Identification of a major storage site purification and characterization. J Biol Chem 258:7155–7160
Assoian RK, Grotendorst GR, Miller DM, Sporn MB (1984a) Cellular transformation by coordinated action of three peptide growth factors from human platelets. Nature 309:804–806
Assoian RK, Frolik CA, Roberts AB, Miller DM, Sporn MB (1984b) Transforming growth factor-β controls receptor levels for epidermal growth factor in NRK cells. Cell 36:35–41
Assoian RK (1985) Biphasic effects of type β transforming growth factor on epidermal growth factor receptors in NRK fibroblasts. J Biol Chem 260:9613–9617
Bradshaw GL, Dubes GR (1983) Supplementary factors required for serum-free culture of rat kidney cells of line NRK-49F. In vitro 19:735–742
Brown KD, Holley RW (1987) Insulin-like synergistic stimulation of DNA synthesis in Swiss 3T3 cells by the BSC-1 cell-derived growth inhibitor related to transforming growth factor type β. Proc Natl Acad Sci USA 84:3743–3747
Cheifetz S, Weatherbee JA, Tsang MLS, Anderson JK, Mole JE, Lucas R, Massagué J (1987) The transforming growth factor-β system a complex pattern of cross-reactive ligands and receptors. Cell 48:409–415
Childs CB, Proper JA, Tucker RF, Moses HL (1982) Serum contains a platelet-derived transforming growth factor. Proc Natl Acad Sci USA 79:5312–5316
Cinofe MA, Fidler IJ (1980) Correlation of patterns of anchorage-independent growth with in vivo behaviour of cells from a murine fibrosarcoma. Proc Natl Acad Sci USA 77:1039–1043
Coffey RJ, Leof EB, Shipley GD, Moses HL (1987) Suramin inhibition of growth factor receptor binding and mitogenicity in AKR-2B cells. J Cell Physiol 132:143–148
DeLarco JE, Todaro GJ (1978) Growth factors from murine sarcoma virus-transformed cells. Proc Natl Acad Sci USA 75:4001–4005
Derynck R (1986) Transforming growth factor-α: structure and biological activities. J Cell Biochem 32:293–304
Fava RA, McClure DB (1987) Fibronectin-associated transforming growth factor. J Cell Physiol 131:184–189
Frolik CA, Roller PP, Cone JL, Dart LL, Smith DM, Sporn MB (1984) Inhibition of transforming growth factor-induced cell growth in soft agar by oxidized polyamines. Arch Biochem Biophys 230:93–102
Giguere V, Ong ES, Segui P, Evans RM (1987) Identification of a receptor for the morphogen retinoic acid. Nature 330:624–629
Goustin AS, Leof EB, Shipley GD, Moses HL (1986) Growth factors and cancer. Cancer Res 46:1015–1029
Goustin AS, Nuttall GA, Leof EB, Ranganathan G, Moses HL (1987) Transforming growth factor type β can act as a potent competence factor for AKR-2B cells. Exp Cell Res 172:293–303
Heldin CH, Westermark B (1984) Growth factors: mechanism of action and relation to oncogenes. Cell 37:9–20
Ignotz RA, Massagué J (1986) Transforming growth factor-β stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 261:4337–4345
Jetten AM (1983) Action of retinoids on the anchorage-independent growth of normal rat kidney fibroblasts induced by 12–0-tetradecanoyl phorbol-13-acetate or sarcoma growth factor. Cancer Res 43:68–72
Kaplan PL, Anderson M, Ozanne B (1982) Transforming growth factor(s) production enables cells to grow in the absence of serum: an autocrine system. Proc Natl Acad Sci USA 79:485–489
Kaplan PL, Ozanne B (1983) Cellular responsiveness to growth factors correlates with a cell’s ability to express the transformed phenotype. Cell 33:931–938.
Leof EB, Proper JA, Goustin AS, Shipley GD, DiCorleto PE, Moses HL (1986) Induction of c—sis mRNA and activity similar to platelet-derived growth factor by transforming growth factor β: a proposed model for indirect mitogenesis involving autocrine activity. Proc Natl Acad Sci USA 83:2453–2457
Levine AE, Crandall CA (1987) Effects of N, N dimethyl formamide and retinoic acid on transforming growth factor—β induced mitogenesis in AKR—2B mouse embryo fibroblasts. Cancer Res 47:4278–4282
Libby J, Martinez R, Weber MJ (1986) Tyrosine phosphorylation in cells treated with transforming growth factor-β. J Cell Physiol 129:159–166
Massagué J (1985a) Transforming growth factor—β modulates the high—affinity receptors for epidermal growth factor and transforming growth factor-α. J Cell Biol 100:1508–1514
Massagué J, Kelly B, Mottola C (1985b) Stimulation by insulin-like growth factors is required for cellular transformation by type β transforming growth factor. J Biol Chem 260:4551–4554
Moses HL, Tucker RF, Leof EB, Coffey RJ, Halper J, Shipley GD (1985) Type-β transforming growth factor is a growth stimulator and a growth inhibitor. In: “Growth factor and Transformation”. Cancer cells 3:65–71. Cold Spring Harbor Laboratory
Ozanne B, Wheeler T, Kaplan PL (1982) Cells transformed by RNA and DNA tumor viruses produce transforming growth factors. Feder Proceed 41:3004–3007
Petkovich M, Brand NJ, Krust A, Chambon P (1987) A human retinoic acid receptor which belongs to the family of nuclear receptors. Nature 330:444–450
Rapp UR, Gunnell M, Marquardt H (1983) Normal mouse serum contains peptides with induce fibroblasts to grow in soft agar. J Cell Biochem 21:29–38
Rizzino A (1984) Behavior of transforming growth factors in serum—free media: an improved assay for transforming growth factors. In vitro 20:815–822
Rizzino A, Ruff E, Rizzino H (1986) Induction and modulation of anchorage—independent growth by platelet-derived growth factor fibroblast growth factor and transforming growth factor-β. Cancer Res 46:2816–2820
Roberts AB, Anzano MA, Lamb LC, Smith JM, Sporn MB (1984) Antagonistic actions of retinoic acid and dexamethasone on anchorage—independent growth and epidermal growth factor binding of normal rat kidney cells. Cancer Res 44:1635–1641
Schroder EW, Rapaport E, Black PH (1983) Retinoids and cell proliferation. Cancer Surveys 2:223–241
Shin SI, Freedman VH, Risser R, Pollack R (1975) Tumorigenicity of virus-transformed cells in nude mice is correlated specifically with anchorage—independent growth in vitro. Proc Natl Acad Sci USA 72:4435–4439
Shipley GD, Tucker RF, Moses HL (1985) Type β transforming growth factor/growth inhibitor stimulates entry of monolayer cultures of AKR—2B cells into S phase after a prolonged prereplicative interval. Proc Natl Acad Sci USA 82: 4147–4151
Sporn MB, Roberts AB, Wakefield LM, de Crombrugghe B (1987) Some recent advances in the chemistry and biology of transforming growth factor—beta. J Cell Biol 105:1039–1045
Timmers HTM, Van Zoelen EJJ, Bos JL, Van der Eb AJ (1988) Cells transformed by adenovirus type 12 but not by type 5 are dependent on insulin or insulin—like growth factor I for their proliferation. J Biol Chem 263:1329–1335
Todaro GJ, De Larco JE, Sporn MB (1987) Retinoids block phenotypic cell transformation produced by sarcoma growth factor. Nature 276:272–274
Van der Burg B, Rutteman GR, Blankenstein MA, De Laat SW, Van Zoelen EJJ (1988) Mitogenic Stimulation of human breast cancer cells in a growth factor-defined medium: synergistic action of insulin and estrogen. J Cell Physiol 134:101–108
Van Zoelen EJJ, Van Oostwaard TMJ, Van der Saag PT, De Laat SW (1985) Phenotypic transformation of normal rat kidney cells in a growth factor-defined medium: Induction by a neuroblastoma-derived transforming growth factor independently of the EGF receptor. J Cell Physiol 123:151–160
Van Zoelen EJJ, Van Oostwaard TMJ, De Laat SW (1986) Transforming growth factor-β and retinoic acid modulate phenotypic transformation of normal rat kidney cells induced by epidermal growth factor and platelet-derived growth factor. J Biol Chem 261:5003–5009
Van Zoelen EJJ, Van Rooijen MA, Van Oostwaard TMJ, De Laat SW (1987) Production of transforming growth factors by simian sarcoma virus-transformed cells. Cancer Res 47:1582–1587
Van Zoelen EJJ, Van Oostwaard TMJ, De Laat SW (1988) The role of polypeptide growth factors in phenotypic transformation of normal rat kidney cells. J Biol Chem 263:64–68
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
van Zoelen, E.J.J. (1989). The Role of Polypeptide Growth Factors in Phenotypic Transformation of Normal Rat Kidney Cells. In: de Laat, S.W., Bluemink, J.G., Mummery, C.L. (eds) Cell to Cell Signals in Mammalian Development. NATO ASI Series, vol 26. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-73142-6_22
Download citation
DOI: https://doi.org/10.1007/978-3-642-73142-6_22
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-73144-0
Online ISBN: 978-3-642-73142-6
eBook Packages: Springer Book Archive